Literature DB >> 17234994

Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression.

Jae-Won Shim1, Chang-Hwan Park, Yong-Chul Bae, Jin-Young Bae, Seungsoo Chung, Mi-Yoon Chang, Hyun-Chul Koh, Hyun-Seob Lee, Se-Jin Hwang, Ki-Hwan Lee, Yong-Sung Lee, Cha-Yong Choi, Sang-Hun Lee.   

Abstract

Neural precursor (NP) cells from adult mammalian brains can be isolated, expanded in vitro, and potentially used as cell replacement source material for treatment of intractable brain disorders. Reduced ethical concerns, lack of teratoma formation, and possible ex vivo autologous transplantation are critical advantages to using adult NP donor cells over cells from fetal brain tissue or embryonic stem cells. However, the usage of adult NP cells is limited by the ability to induce specific neurochemical phenotypes in these cells. Here, we demonstrate induction of a dopaminergic phenotype in NP cells isolated from the subventricular zone (SVZ) and white matter of rodent adult brains using overexpression of the nuclear receptor Nurr1 in vitro. Forced expression of Nurr1, a transcriptional factor specific to midbrain dopamine (DA) neuron development, caused in the adult cells an acquisition of the DA neurotransmitter phenotype and sufficient differentiation toward morphologically, phenotypically, and ultrastructurally mature DA neurons. Co-expression of neurogenic factor Mash1 and treatment with neurogenic cytokines brain-derived neurotrophic factor and neurotrophin-3 greatly enhanced Nurr1-induced DA neuron yield. The Nurr1-induced DA neurons demonstrated in vitro presynaptic DA neuronal functionality, releasing DA neurotransmitter in response to depolarization stimuli and specific DA reuptake. Furthermore, Nurr1-engineered adult SVZ NP cells survived, integrated, and differentiated into DA neurons in vivo that can reverse the behavioral deficit in the host striatum of parkinsonian rats. These findings open the possibility for the use of precursor cells from adult brains as a cell source for neuronal replacement treatment of Parkinson disease. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234994     DOI: 10.1634/stemcells.2006-0274

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  27 in total

Review 1.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

2.  Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond.

Authors:  Sarah E Latchney; Amelia J Eisch
Journal:  Eur J Neurodegener Dis       Date:  2012

Review 3.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

Review 4.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

Review 5.  The Role of Direct Current Electric Field-Guided Stem Cell Migration in Neural Regeneration.

Authors:  Li Yao; Yongchao Li
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

Review 6.  Microfluidic systems for stem cell-based neural tissue engineering.

Authors:  Mahdi Karimi; Sajad Bahrami; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Amirala Bakhshian Nik; Amir R Aref; Mohsen Akbari; Michael R Hamblin
Journal:  Lab Chip       Date:  2016-07-05       Impact factor: 6.799

Review 7.  Adult human neural stem cell therapeutics: Current developmental status and prospect.

Authors:  Hyun Nam; Kee-Hang Lee; Do-Hyun Nam; Kyeung Min Joo
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

8.  Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

Authors:  Ester J Kwon; Jurate Lasiene; Berit E Jacobson; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Biomaterials       Date:  2009-12-09       Impact factor: 12.479

Review 9.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

10.  Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant nurr1 mutant.

Authors:  A-Young Jo; Mi-Young Kim; Hyun-Seob Lee; Yong-Hee Rhee; Jeong-Eun Lee; Kwang-Hyun Baek; Chang-Hwan Park; Hyun-Chul Koh; Incheol Shin; Yong-Sung Lee; Sang-Hun Lee
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.